Section 12.45 (21 CFR 12.45) issued
under section 701 of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 371), sets forth the format and procedures for any
interested person to file a petition to participate in a formal
evidentiary hearing, either personally or through a representative.
Section 12.45 requires that any person filing a notice of
participation state their specific interest in the proceedings,
including the specific issues of fact about which the person
desires to be heard. This section also requires that the notice
include a statement that the person will present testimony at the
hearing and will comply with specific requirements in 21 CFR 12.85,
or, in the case of a hearing before a Public Board of Inquiry,
concerning disclosure of data and information by participants (21
CFR 13.25). In accordance with sec. 12.45(e) the presiding officer
may omit a participant's appearance.
The program change resulting in
a burden increase is due to the consolidation of 0910-0183,
0910-0184 and 0910-0191 as these all deal with administrative
procedures.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.